Autor: admin
-
On the single opinion for multicentre non-drug observational studies
IRAD-FEOR documentation Single opinion in multicentre non-drug observational studies Document related to the reassessment of multicentre non-drug observational studies that already have a positive opinion from an IEC. Problem description In multicentre non-drug observational studies, it is common for many participating centres to require reassessment of studies that already have a positive opinion from an […]Leer más -
How to apply for an IRAD-FEOR J&J 2025 grant? Methodology and evaluation committee
IRAD-FEOR video IRAD-FEOR grant application process and 2025 Project Fund Presentation on the IRAD-FEOR grant application process and the new call for the IRAD-FEOR 2025 Radiation Oncology Research Project Fund. Presentation Drs Mikel Eguiguren Bastida and Marian Gómez Aparicio, together with the director of the IRAD Institute, present and explain in depth the IRAD-FEOR grant […]Leer más -
We must invest wisely
IRAD-FEOR documentation Research is crucial and resources are finite Reflection on the need for oncology research in surgery and radiotherapy, based on the analysis of investment allocated to these areas. Contexto Research is crucial and resources are finite. The main treatments for most solid tumours are surgery and radiotherapy. In 2015, it was estimated that […]Leer más -
I BOLSA DE PROYECTOS IRAD-FEOR 2025
Convocatoria IRAD-FEOR I Bolsa de Proyectos IRAD-FEOR 2025 Convocatoria orientada a identificar e impulsar iniciativas investigadoras prometedoras en Oncología Radioterápica, con rigor científico y potencial impacto clínico o básico. Objetivo de la convocatoria IRAD busca fomentar la investigación en Oncología Radioterápica y crear alianzas estratégicas que impulsen el desarrollo de innovaciones científicas y tecnológicas en […]Leer más -
1st IRAD-FEOR Project Fund 2025
IRAD-FEOR call 1st IRAD-FEOR Project Fund 2025 Call aimed at identifying and promoting promising research initiatives in Radiation Oncology, with scientific rigour and potential clinical or basic impact. Objective of the call IRAD seeks to promote research in Radiation Oncology and create strategic alliances that drive the development of scientific and technological innovations in the […]Leer más -
Convocatoria del Premio 60 Aniversario Farmaindustria Jóvenes Investigadores
Premios de investigación Premio 60 Aniversario Farmaindustria Jóvenes Investigadores Convocatoria dirigida a reconocer la trayectoria de un joven científico o investigador de menos de 40 años que esté contribuyendo de forma significativa al desarrollo de la actividad investigadora en España. Objetivo del premio Como colofón a su 60 aniversario, Farmaindustria ha convocado el Premio 60 […]Leer más -
Convocatoria Fondo de Investigaciones Sanitarias (FIS)
Convocatoria de investigación Acción Estratégica en Salud AES 2024 Resolución de la convocatoria correspondiente al año 2024 de la Acción Estratégica en Salud, en el marco del Plan Estatal de Investigación Científica, Técnica y de Innovación 2021-2023. Resolución de la convocatoria El Instituto de Salud Carlos III (ISCIII), adscrito al Ministerio de Ciencia, Innovación y […]Leer más -
Call for the Health Research Fund (FIS)
Research call Strategic Health Action AES 2024 Resolution of the 2024 call for the Strategic Health Action, within the framework of the State Plan for Scientific, Technical and Innovation Research 2021-2023. Call resolution The Instituto de Salud Carlos III (ISCIII), attached to the Ministry of Science, Innovation and Universities, has today published the resolution of […]Leer más -
Last days to submit nominations for the Ramiro Carregal Oncology Research Awards
Research awards Ramiro Carregal Oncology, Scientific and Technical Research Awards Open call for nominations for the 12th International Award and the 5th Emerging Talent Award. Submission deadline The deadline for submitting nominations for the Ramiro Carregal Oncology, Scientific and Technical Research Awards is open until 30 January 2024 at 23:59. The call includes the 12th […]Leer más